导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 34.81% | 107/1050 |
| 近一周 | -1.83% | 332/1104 |
| 近一月 | -7.12% | 833/1102 |
| 近一季 | -17.36% | 909/1092 |
| 近半年 | 23.03% | 113/1070 |
| 近一年 | 32.40% | 147/1018 |
| 近两年 | 110.98% | 158/926 |
| 近三年 | 88.79% | 109/834 |
| 成立以来 | 266.04% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.55% 293/1070 |
97.11% 56/1101 |
- - |
- - |
| 2025 | 21.50% 639/1065 |
7.44% 253/1014 |
-0.07% 691/1038 |
20.91% 582/1050 |
-6.40% 764/1065 |
| 2024 | 25.95% 43/1011 |
6.91% 64/960 |
-3.19% 519/983 |
17.84% 104/991 |
3.27% 190/1011 |
| 2023 | -14.98% 521/952 |
1.36% 549/880 |
-12.42% 818/895 |
3.57% 13/915 |
-7.53% 727/952 |
| 2022 | -15.18% 180/867 |
-19.54% 497/773 |
18.44% 39/806 |
-11.85% 376/845 |
0.96% 387/867 |
| 2021 | 5.18% 300/740 |
9.70% 11/580 |
6.88% 430/659 |
-13.69% 587/704 |
3.94% 263/740 |
| 2020 | 40.75% 295/554 |
-9.29% 374/419 |
19.19% 300/466 |
16.97% 107/517 |
11.29% 322/554 |
| 2019 | 87.84% 3/410 |
39.84% 67/1149 |
10.39% 11/1231 |
2.91% 257/390 |
18.24% 22/410 |
| 2018 | -14.77% 25/349 |
- - |
- - |
- - |
-9.21% 234/1080 |
| 2017 | -0.32% 178/285 |
- - |
- - |
- - |
- - |
| 2016 | 0.73% 27/205 |
- - |
- - |
- - |
- - |
| 2015 | 47.06% 31/151 |
- - |
- - |
- - |
- - |
| 2014 | 33.49% 6/24 |
- - |
- - |
- - |
- - |
| 2013 | -10.12% 21/21 |
- - |
- - |
- - |
- - |
| 2012 | 2.56% 297/459 |
- - |
- - |
- - |
- - |
| 2011 | -28.12% 309/392 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 天弘文化新兴产业股票A VS. 东吴新产业精选股票A(580008) |